University at Buffalo - The State University of New York
Skip to Content
Anthony                        Campagnari

Anthony A. Campagnari PhD

Department of Microbiology and Immunology

Professor of Microbiology/Immunology and Medicine

Specialty/Research Focus

Bacterial Pathogenesis; Infectious Disease; Microbial Pathogenesis; Microbiology

Professional Summary:

My research interests focus on bacterial pathogenesis, emphasizing bacterial biofilms, antimicrobial therapies and vaccine antigens. One major area of my research lab is otitis media (OM) or middle ear disease. Approximately 80 percent of children experience one episode of OM while others have recurrent infections. Chronic OM infection causes hearing impairment leading to developmental problems as these children reach school age. My laboratory has concentrated on two major causes of OM, Moraxella catarrhalis and Streptococcus pneumoniae. Our recent work suggests that M. catarrhalis colonization predisposes patients to colonization with S. pneumoniae in polymicrobial biofilms. The goals of this work are to define biofilm-associated factors and to identify signals that induce bacteria to transition from asymptomatic colonizers to pathogenic organisms leading to OM.

Our second major research focus is the identification of novel antimicrobial therapies. Chronic OM is likely a biofilm-associated disease and biofilms are highly antibiotic resistant. Antibiotic resistance is a major problem worldwide and new drug development is both time consuming and extremely expensive. We have demonstrated that photodynamic therapy (PDT), an FDA-approved cancer treatment, is also bactericidal against the three major otopathogens. Thus, the goal of this research is to adapt PDT into a clinically effective treatment for chronic OM.

Our third research area involves novel antimicrobial treatments for orthopedic/prosthetic infections. Infections after orthopedic intervention, including knee/hip replacements and insertion of prosthetic devices, are devastating to the patient and these infections will likely increase over the next 20 years. This is particularly relevant to the military where improvised explosive devices cause severe extremity injuries requiring amputation. Antibiotic-resistant biofilms are the primary source of these infections. In collaboration with colleagues at UB, we are testing a novel electrical stimulation method for prevention/eradication of biofilm infections on implant materials. The goals of this research are to define the optimal antimicrobial parameters that are broadly effective against multiple pathogens, including Staphylococcus aureus, Acinetobacter baumannii, Staphylococcus epidermidis and Klebsiella pneumoniae.

The members of my research team typically include a combination of graduate students, lab technicians and a junior faculty member. In the summer, I usually mentor medical students or undergraduates who are interested in the fundamentals of basic science and translational research focused on microbial pathogenesis.

Education and Training:
  • PhD, Tumor Immunology, University at Buffalo (1984)
  • MS, Biochemistry, University at Buffalo (1981)
  • Senior Associate Dean for Research and Graduate Education, Microbiology and Immunology, University at Buffalo (2013-present)
  • Professor of Microbiology, Immunology and Medicine, Microbiology and Immunology, University at Buffalo (2001-present)
  • Associate Professor, Medicine, University at Buffalo (1999–2001)
  • Associate Professor, Microbiology and Immunology, University at Buffalo (1996–2001)
  • Research Assistant Professor, Medicine, University at Buffalo (1987–1999)
  • Adjunct Assistant Professor, Microbiology and Immunology, University at Buffalo (1992–1996)
  • Instructor, Medicine, University at Buffalo (1985–1987)
  • Post Doctoral Fellow, Division of Infectious Diseases, University at Buffalo (1983–1985)
Awards and Honors:
  • UB Distinguished Biomedical Alumnus (2107)
  • Fellow in the American Academy for Microbiology (2017)
  • SUNY Chancellor's Award (2017)
  • Deans Award 2016 (2016)
  • Stockton Kimball (2016)
  • UB Excellence in Graduate Student Mentoring Award (2015)
  • Elected to the College of CSR Reviewers National Institutes of Health (2010)
  • UB Inventor and Entrepreneur Award (2009)
  • UB Visionary Innovator Award (2008)
  • Sustained Achievement Award (2002)

Research Expertise:
  • Antibody development: Development of monoclonal and polyclonal antibodies.
  • Bacterial pathogenesis: Identification of biofilm associated factors. Characterizing bacterial components involved in biofilm formation and stability.
  • Microbial pathogenesis: Colonization factors; virulence determinants
  • Novel antimicrobial therapy: Analyzing photo dynamic therapy and electrical stimulation as potential treatments for infections caused by antibiotic resistant bacteria.
  • Vaccine development: Identification of colonization and virulence factors and vaccine antigens
Grants and Sponsored Research:
  • May 2016–April 2021
    National Institutes of Deafness and Communicative Disorders
    Role: Principal Investigator
  • March 2014–February 2019
    Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
    Role: Principal Investigator
  • October 2012–September 2014
    Analysis of Novel Acinetobacter baumannii Adhesions
    Role: Principal Investigator
  • April 2013–April 2014
    A Novel Electrical Stimulation Method for the Eradication/Preventions of Orthopedic Biofilms
    Bruce Holm Memorial Catalyst Fund
    Role: Co-Principal Investigator
  • October 2010–October 2013
    Electrical Stimulation of Titanium for the Prevention and/or Eradication of A. baumannii and S. aureus Biofilm Infections on Osseointegrated Prostheses
    Congressionally Directed Medical Research Program-Peer Reviewed Orthopaedic Research Program
    Role: Co-Investigator
  • November 2007–December 2012
    Genetics & Biology of M. catarrhalis LOS in Otitis Media
    Role: Principal Investigator
  • September 2002–September 2007
    Genetics & Biology of M. catarrhalis LOS in Otitis Media
    Role: Principal Investigator
  • November 2002–November 2005
    Comprehensive Analysis of Virulence Factors and Potential Vaccine Antigens of Haemophilus ducreyi.
    The John R. Oishei Foundation
    Role: Principal Investigator
  • August 2001–July 2005
    Analysis of Moraxella catarrhalis LOS: Role in Immunity
    National Institute of Allergy and Infectious Diseases
    Role: Principal Investigator
  • February 2000–January 2005
    Analysis of M. catarrhalis receptors as Vaccine Antigens
    National Institute of Allergy and Infectious Diseases
    Role: Principal Investigator
  • June 2002–May 2004
    Capture, Isolation and Identification of Biologic Agents
    New York State Center for Applied Technology
    Role: Principal Investigator
  • June 2001–May 2002
    Development of Monoclonal Antibodies
    University Service Account
    Role: Principal Investigator
  • June 1997–May 2002
    Structure of Haemophilus ducreyi LOS: Role in Adherence/Invasion
    National Institute of Allergy and Infectious Diseases
    Role: Principal Investigator
See all (3 more)
  • Novel stimulation technology Electrochemical eradication of microbes on surfaces of objects (2017)
  • Tools for Detecting Moraxella catarrhalis (2008)
  • PCR modification USA patent No. 5,871,906 titled; Method for the Detection of Amplified Nucleic Acid Products and Related Diagnostic Assays, 1999. (1999)
  • Moraxella catarrhalis a vaccine antigen. USA patent No. 6,004,562 (1999)
  • Concentrator/Detector USA patent No. 4,859,421 titled; Disposable Antigen Concentrator and Detector and Methods for Using Same. (1989)

Journal Articles:
  • Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect Immun. 2008; 76(8).
  • Brooks EK, Ahn R, Tobias ME, Hansen LA, Luke-Marshall NR, Wild L, Campagnari AA, Ehrensberger MT. Magnesium alloy AZ91 exhibits antimicrobial properties in vitro but not in vivo. J Biomed Mater Res B Appl Biomater. 2017.
  • Reddinger RM, Luke-Marshall NR, Hakansson AP, Campagnari AA. Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease. MBio. 2016; 7(4).
  • Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2015; 33(43).
  • Nodzo S, Tobias M, Hansen L, Luke-Marshall NR, Cole R, Wild L, Campagnari AA, Ehrensberger MT. Cathodic Electrical Stimulation Combined With Vancomycin Enhances Treatment of Methicillin-resistant Staphylococcus aureus Implant-associated Infections. Clin Orthop Relat Res. 2015.
  • Ehrensberger MT, Tobias ME, Nodzo SR, Hansen LA, Luke-Marshall NR, Cole RF, Wild LM, Campagnari AA. Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for methicillin-resistant Staphylococcus aureus periprosthetic infections. Biomaterials. 2015; 41.
  • Luke-Marshall NR, Mang TS, Hansen LA, Campagnari AA. Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin. Lasers Surg Med. 2014.
  • Luke-Marshall NR, Edwards KJ, Sauberan S, St Michael F, Vinogradov EV, Cox AD, Campagnari AA. Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly. Glycobiology. 2013; 23(8).
  • Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012; 80(1).
  • Brossard KA, Campagnari AA. The Acinetobacter baumannii Biofilm Associated Protein (Bap) Plays a Role in Adherence to Human Epithelial Cells. Infect Immun. 2011.
  • Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun. 2010; 78(9).
  • Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect Immun. 2010; 78(5).
  • Schwingel JM, Edwards KJ, Cox AD, Masoud H, Richards JC, St Michael F, Tekwe CD, Sethi S, Murphy TF, Campagnari AA. Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Infect Immun. 2009; 77(10).
  • Schwingel JM, St Michael F, Cox AD, Masoud H, Richards JC, Campagnari AA. A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology. 2008; 18(6).
  • Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol. 2008; 190(3).
  • Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol. 2008; 190(24).
  • Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007; 75(12).
  • Plamondon P, Luke NR, Campagnari AA. Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infect Immun. 2007; 75(6).
  • Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers. Microb Pathog. 2006; 40(3).
  • Edwards KJ, Allen S, Gibson BW, Campagnari AA. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J Bacteriol. 2005; 187(9).
  • Furano K, Luke NR, Howlett AJ, Campagnari AA. Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology. 2005; 151(Pt 4).
  • Furano K, Campagnari AA. Identification of a hemin utilization protein of Moraxella catarrhalis (HumA). Infect Immun. 2004; 72(11).
  • Prather DT, Bains M, Hancock RE, Filiatrault MJ, Campagnari AA. Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi. Infect Immun. 2004; 72(11).
  • Luke NR, Howlett AJ, Shao J, Campagnari AA. Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infect Immun. 2004; 72(11).
  • Luke NR, Allen S, Gibson BW, Campagnari AA. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.. Infect Immun. 2003; 71(11).
  • Furano K, Campagnari AA. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera.. Infect Immun. 2003; 71(4).
  • Schilling B, Gibson BW, Filiatrault M, Campagnari AA. Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats.. J Am Soc Mass Spectrom. 2002; 13(6).
  • Tullius MV, Phillips NJ, Scheffler NK, Samuels NM, Munson Jr RS, Hansen EJ, Stevens-Riley M, Campagnari AA, Gibson BW. The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.. Infect Immun. 2002; 70(6).
  • Luke NR, Karalus RJ, Campagnari AA. Inactivation of the Moraxella catarrhalis Superoxide Dismutase SodA Induces Constitutive Expression of Iron-Repressible Outer Membrane Proteins.. Infect Immun. 2002; 70(4).
  • Filiatrault MJ, Munson RS, Anthony Campagnari. Genetic Analysis of a Pyocin-Resistant Lipooligosaccharide (LOS) Mutant of Haemophilus ducreyi: Restoration of Full-Length LOS Restores Pyocin Sensitivity.. J Bacteriol. 2001; 183(19).
  • Young RS, Filiatrault MJ, Fortney KR, Hood AF, Katz BP, Munson RS, Anthony Campagnari, Spinola SM. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.. Infect Immun. 2001; 69(6).
  • Zaleski A, Scheffler NK, Densen P, Lee FK, Anthony Campagnari, Gibson BW, Apicella MA. Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.. Infect Immun. 2000; 68(9).
  • Filiatrault MJ, Gibson BW, Schilling B, Sun S, Munson RS, Campagnari AA. Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats.. Infect Immun. 2000; 68(6).
  • Yu H, Raymonda JW, McMahon TM, Anthony Campagnari. Detection of biological threat agents by immunomagnetic microsphere-based solid phase fluorogenic- and electro-chemiluminescence.. Biosens Bioelectron. 2000; 14(10-11).
  • Young RS, Fortney K, Haley JC, Hood AF, Anthony Campagnari, Wang J, Bozue JA, Munson RS, Spinola SM. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.. Infect Immun. 1999; 67(12).
  • Luke NR, Anthony Campagnari. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.. Infect Immun. 1999; 67(11).
  • Luke NR, Thomas Russo, Luther N, Anthony Campagnari. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.. Infect Immun. 1999; 67(2).
  • Inzana TJ, Hensley J, McQuiston J, Alan Lesse, Anthony Campagnari, Boyle SM, Apicella MA. Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.. Infect Immun. 1997; 65(11).
  • Gibson BW, Anthony Campagnari, Melaugh W, Phillips NJ, Apicella MA, Grass S, Wang J, Palmer KL, Munson RS. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis.. J Bacteriol. 1997; 179(16).
  • Hiltke TJ, Anthony Campagnari, Spinola SM. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi.. Infect Immun. 1996; 64(12).
  • Anthony Campagnari, Ducey TF, Rebmann CA. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin.. Infect Immun. 1996; 64(9).
  • Spinola SM, Orazi A, Arno JN, Fortney K, Kotylo P, Chen CY, Anthony Campagnari, Hood AF. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection.. J Infect Dis. 1996; 173(2).
  • Melaugh W, Anthony Campagnari, Gibson BW. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.. J Bacteriol. 1996; 178(2).
  • Thomas Russo, Sharma G, Brown CR, Anthony Campagnari. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.. Infect Immun. 1995; 63(4).
  • Melaugh W, Phillips NJ, Anthony Campagnari, Tullius MV, Gibson BW. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms.. Biochemistry. 1994; 33(44).
  • Anthony Campagnari, Shanks KL, Dyer DW. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production.. Infect Immun. 1994; 62(11).
  • Westerink MA, Anthony Campagnari, Giardina P, Apicella MA. Antiidiotype antibodies as surrogates for polysaccharide vaccines.. Ann N Y Acad Sci. 1994; 730.
  • Anthony Campagnari, Karalus R, Apicella M, Melaugh W, Alan Lesse, Gibson BW. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis.. Infect Immun. 1994; 62(6).
  • Spinola SM, Linda Wild, Apicella MA, Gaspari AA, Anthony Campagnari. Experimental human infection with Haemophilus ducreyi.. J Infect Dis. 1994; 169(5).
  • Brentjens RJ, Spinola SM, Anthony Campagnari. Haemophilus ducreyi adheres to human keratinocytes.. Microb Pathog. 1994; 16(3).
  • Gibson BW, Melaugh W, Phillips NJ, Apicella MA, Anthony Campagnari, Griffiss JM. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.. J Bacteriol. 1993; 175(9).
  • Melaugh W, Phillips NJ, Anthony Campagnari, Karalus R, Gibson BW. Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease.. J Biol Chem. 1992; 267(19).
  • Sarwar J, Anthony Campagnari, Kirkham C, Murphy TF. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.. Infect Immun. 1992; 60(3).
  • Anthony Campagnari, Linda Wild, Griffiths GE, Karalus RJ, Wirth MA, Spinola SM. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.. Infect Immun. 1991; 59(8).
  • Haase EM, Anthony Campagnari, Sarwar J, Shero M, Wirth M, Cumming CU, Murphy TF. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae.. Infect Immun. 1991; 59(4).
  • Westerink MA, Giardina PC, Anthony Campagnari, Apicella MA. The thymus-dependent nature of the murine antibody response to a monoclonal anti-idiotypic antibody to the Neisseria meningitidis serogroup C capsular polysaccharide.. Microb Pathog. 1990; 8(6).
  • Spinola SM, Kwaik YA, Alan Lesse, Anthony Campagnari, Apicella MA. Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope.. Infect Immun. 1990; 58(6).
  • Anthony Campagnari, Spinola SM, Alan Lesse, Kwaik YA, Mandrell RE, Apicella MA. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.. Microb Pathog. 1990; 8(5).
  • Alan Lesse, Anthony Campagnari, Bittner WE, Apicella MA. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.. J Immunol Methods. 1990; 126(1).
  • Fukatsu A, Yuzawa Y, Olson L, Miller J, Milgrom M, Zamlauski-Tucker MJ, Van Liew JB, Anthony Campagnari, Niesen N, Patel J. Interaction of antibodies with human glomerular epithelial cells.. Lab Invest. 1989; 61(4).
  • Murphy TF, Anthony Campagnari, Nelson MB, Apicella MA. Somatic antigens of Haemophilus influenzae as vaccine components.. Pediatr Infect Dis J. 1989; 8(1 Sup).
  • Westerink MA, Anthony Campagnari, Nelson MB, Murphy TF, Apicella MA. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.. Adv Exp Med Biol. 1989; 251.
  • Westerink MA, Anthony Campagnari, Wirth MA, Apicella MA. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.. Infect Immun. 1988; 56(5).
  • Murphy TF, Bernstein JM, Dryja DM, Anthony Campagnari, Apicella MA. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypable Haemophilus influenzae: pathogenetic and epidemiological observations.. J Infect Dis. 1987; 156(5).
  • Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae.. Infect Immun. 1987; 55(4).
  • Murphy TF, Bartos LC, Anthony Campagnari, Nelson MB, Apicella MA. Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae.. Infect Immun. 1986; 54(3).
  • Harvey, S., Douglass, H.O., Holyoke, E.D. and Goldrosen, M.H.. Localization of an acidic protein isolated from the effusion fluid of patients with pancreatic cancer.. Tumor Diagnostik and Therapie.. 1986; 7.
  • Apicella MA, Dudas KC, Anthony Campagnari, Rice P, Joseph Mylotte, Murphy TF. Antigenic heterogeneity of lipid A of Haemophilus influenzae.. Infect Immun. 1985; 50(1).
  • Harvey, S., Douglass, H.O., Holyoke, E.D. and Goldrosen, M.H.. Detection, isolation and biochemical characterization of an acidic protein from the effusion fluid of patients with pancreatic cancer.. Tumor Diagnostik and Therapie.. 1985; 6.
  • Goldrosen MH, Anthony Campagnari, Howell JH, Harvey S, Jenkins D, Berjian R, Harold Douglass. Immunodiagnosis of pancreatic cancer.. Prog Clin Biol Res. 1983; 133.
See all (60 more)
Evaluative Studies and Case Reports:

Professional Memberships:
  • American Association for the Advancement of Science (2010–present)
  • New York Academy of Sciences (1997–present)
  • Western New York Branch of ASM (1987–present)
  • American Society for Microbiology (1986–present)
  • "Identification and Characterization of an Acinetobacter baumannii Surface Component Involved in Biofilm Formation and Stability" Conversations in Global Health., SUNY Upstate Medical University (2013)
  • "Potential Vaccine Antigens Versus Moraxella catarrhalis" 10th International Symposium on Recent Advances in Otitis Media. (2011)
  • "Biofilm factors of Acinetobacter baumannii" Departmental Seminar, University of Nebraska Medical Center (2011)
  • "The Role of Surface Carbohydrates in Acinetobacter baumannii Pathogenesis" Departmental Seminar, Emory University (2010)
  • "Identification and Characterization of Acinetobacter baumannii Surface Components Involved in Biofilm Formation and Stability" Departmental Seminar, University of Texas, Southwest Medical Center (2009)
  • "Identification and Characterization of an Acinetobacter baumannii Biofilm-Associated Protein" USAMRMC MIDRP W Wound Conference, WRAIR/NMRC facility (2009)
  • "Expression of a large Surface Protein on Acinetobacter baumannii Correlates with Biofilm Formation and Stability" Departmental Seminar, University of Oklahoma Health Sciences Center (2008)
  • "A Novel Two-Partner Secretion Pathway of Moraxella catarrhalis" Departmental Seminar, SUNY at Buffalo/Oral Biology (2006)
  • "Type IV Pilus Expression by Moraxella catarrhalis" Departmental Seminar, Wake Forest University School of Medicine (2006)
  • "Is Type IV Pilus Expression by Moraxella catarrhalis Essential for Pathogenesis?" Departmental Seminar, Medical College of Ohio (2005)
  • "Virulence Factors for Moraxella catarrhalis" Departmental Seminar, Allegheny-Singer Research Institute, Center for Genomic Sciences, Allegheny General Hospital (2004)
  • "Potential Vaccine Antigens for the Prevention of Moraxella catarrhalis Induced Otitis Media." Otitis Media: New Approaches for Analysis, Treatment and Prevention, NIH, NICDCD (2000)
  • "Moraxella catarrhalis Lipooligosaccharides; Unique Glycolipids" Departmental Seminar, Ohio State University, Department of Molecular Microbiology, Immunology and Bacteriology (2000)
  • "Iron-regulated Proteins of Moraxella catarrhalis" Departmental Seminar, SUNY@Buffalo, Oral Biology (1999)
  • "Iron-regulated Protein Expression by Moraxella catarrhalis may be Important for Sensitivity to Human Complement." Research Exchange Series, SUNY@Buffalo, Center for Advanced Molecular Biology and Immunology (1997)
  • "Potential Cell Surface Receptors for Haemophilus ducreyi LOS Expressed on Human Keratinocytes" Departmental Seminar, University of California at San Francisco, Pharmaceutical Chemistry (1997)
  • "Iron-repressible proteins expressed during infections caused by Moraxella (Branhamella) catarrhalis" Fall Conference Microbial Pathogenesis, SUNY@Buffalo, Microbial Pathogenesis Graduate Group (1996)
  • "The immune response to Iron-regulated proteins expressed during otitis media caused by Moraxella catarrhalis" Departmental Seminar, Children’s Hospital of Buffalo, Department of Pediatric Infectious Diseases (1996)
  • "The major lipooligosaccharide (LOS) structure conserved on the surface of different Haemophilus ducreyi strains, binds to proteins expressed by human keratinocytes in vitro." American Society for Microbiology, 95th general meeting., American Society for Microbiology, Microbial Pathogenesis (1995)
  • "The role of the Lipooligosaccharides in Haemophilus ducreyi adherence and invasion of human cells" Departmental Seminar, SUNY at Buffalo, Department of Microbiology (1995)
  • "Iron-regulated proteins of Moraxella catarrhalis" Infectious Diseases Research Conference, SUNY at Buffalo, Department of Medicine (1994)
  • "A Tn916 Lipooligosaccharide (LOS) Mutant of Haemophilus ducreyi Shows a Decreased Ability to Adhere to and Invade Human Keratinocytes." 94th General Meeting, American Society for Microbiology, Microbial Pathogenesis (1994)
  • "Development and Current Uses for Monoclonal Antibodies." Current Trends in Clinical Laboratory Medicine, SUNY at Buffalo, Department of Medical Technology (1994)
  • "The Role of the Lipooligosaccharides in the Pathogenesis of Haemophilus ducreyi" Western New York Branch of the American Society for Microbiology, WNY ASM (1993)
  • "Advancements in the Development of Bacterial Vaccines; Anti-idiotypic Antibodies" City Wide Grand Rounds, SUNY at Buffalo, Department of Medicine (1992)
  • "The Role of LOS in Experimental Dermal Lesions Caused by Haemophilus ducreyi" The Molecular Immunology of Sexually Transmitted Diseases, NIH, Rocky Mountain Laboratories, NIAID, National Vaccine Program, CDC, FDA and the Department of Defense (1991)
  • "Monoclonal Antibodies and Recombinant DNA Technology" Advances in Immunology, New State Council of Hospital Pharmacists (1989)
See all (17 more)
Service Activities:
  • Microbiology and Immunology, Jacobs School of Medicine & Biomedical Sciences Graduate Affairs; Director (2000–2002)
  • Microbiology and Immunology, Jacobs School of Medicine & Biomedical Sciences Graduate Affairs; Member (1998–2000)
  • Journal of Endotoxin Research.; Ad hoc reviewer for the Journal of Endotoxin Research.; Ad Hoc Reviewer (2001–present)
  • Microbial Pathogenesis Graduate Group.; Director of the Microbial Pathogenesis Graduate Group.; Director (2000–2002)
  • Infection and Immunity.; Editorial board of Infection and Immunity.; Editorial Board Member (2000–present)
  • Director of Admissions and Recruiting MSTP.; Director of Admissions and Recruiting Medical Scientist Training Program.; Director (2000–2001)
  • Director of Graduate Studies.; Director of the graduate program, Department of Microbiology.; Director (2000–2002)
  • Faculty Search Committee.; Member of the Immunology Faculty Search Committee, Department of Microbiology.; Member (2000)
  • Preliminary Examination.; Chairman of the Preliminary Examination Committee Department of Microbiology.; Ad Hoc Reviewer (2000)
  • Masters Program.; Director of the masters program, Department of Microbiology.; Director (1999–2000)
  • Director of Recruiting IGPBS; Director of Recruiting Interdisciplinary Graduate Program in the Biomedical Sciences.; Director (1999–2000)
  • Curriculum review.; Member of a special ad hoc subcommittee reviewing BMS 501/502 for the Interdisciplinary Graduate Program.; Department Representative (1998–1999)
  • Institutional Animal Care and Use Committee; Associate Chair of the Institutional Animal Care and Use Committee (IACUC).; Ad Hoc Reviewer (1997–1999)
  • Lecture on HIV and AIDS.; Guest speaker at Our Lady of the Sacred Heart School. Presentation to the eighth grade class, topic “HIV and AIDS”.; Guest Lecturer (1997–present)
  • Push-Excel Career Awareness Day; Guest speaker for Push-Excel Career Awareness Day at the Academic Challenge Center, Buffalo, New York.; Guest Lecturer (1993–present)
  • Monoclonal Center; Director of the Monoclonal Antibody Center.; Director (1992–present)
  • Career Day; Guest speaker at Career Day, Attica Middle School, Attica, New York..; Guest Lecturer (1992–present)
  • Microbial Pathogenesis; Adhoc reviewer Microbial Pathogenesis.; Ad Hoc Reviewer (1992–present)
  • HIV in the community.; Lecture on Viral infections and the Human Immunodeficiency Virus to the Senior Biology Class at Frontier High School, Hamburg, N.Y.; Guest Lecturer (1989–present)
  • AIDS risks.; Informational lecture on AIDS to Western New York Association of Hospital Security Guards.; Guest Lecturer (1988–present)
  • Glycobiology; Ad Hoc Reviewer
  • Journal of Bacteriology; Ad Hoc Reviewer
  • Journal of Infectious Diseases; Ad Hoc Reviewer
  • Journal of Microbiology; Ad Hoc Reviewer
  • Microbiology; Ad Hoc Reviewer
  • Molecular Microbiology; Ad Hoc Reviewer
  • PLOS One; Ad Hoc Reviewer
  • PLOS Pathogens; Ad Hoc Reviewer
  • Vaccine; Ad Hoc Reviewer

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:

Contact Information

3435 Main Street
143 Biomedical Research Building
Buffalo, NY 14214
Phone: (716) 829-2593
Fax: 716-829-3889

Log in to Update Your Profile